JP2022502476A5 - - Google Patents

Info

Publication number
JP2022502476A5
JP2022502476A5 JP2021521024A JP2021521024A JP2022502476A5 JP 2022502476 A5 JP2022502476 A5 JP 2022502476A5 JP 2021521024 A JP2021521024 A JP 2021521024A JP 2021521024 A JP2021521024 A JP 2021521024A JP 2022502476 A5 JP2022502476 A5 JP 2022502476A5
Authority
JP
Japan
Application number
JP2021521024A
Other languages
Japanese (ja)
Other versions
JPWO2020081636A5 (https=
JP2022502476A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/056455 external-priority patent/WO2020081636A1/en
Publication of JP2022502476A publication Critical patent/JP2022502476A/ja
Publication of JPWO2020081636A5 publication Critical patent/JPWO2020081636A5/ja
Publication of JP2022502476A5 publication Critical patent/JP2022502476A5/ja
Pending legal-status Critical Current

Links

JP2021521024A 2018-10-16 2019-10-16 インドールahr阻害剤およびその使用 Pending JP2022502476A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862746277P 2018-10-16 2018-10-16
US62/746,277 2018-10-16
PCT/US2019/056455 WO2020081636A1 (en) 2018-10-16 2019-10-16 Indole ahr inhibitors and uses thereof

Publications (3)

Publication Number Publication Date
JP2022502476A JP2022502476A (ja) 2022-01-11
JPWO2020081636A5 JPWO2020081636A5 (https=) 2022-10-25
JP2022502476A5 true JP2022502476A5 (https=) 2022-10-25

Family

ID=70284697

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021521024A Pending JP2022502476A (ja) 2018-10-16 2019-10-16 インドールahr阻害剤およびその使用

Country Status (13)

Country Link
US (1) US20220144839A1 (https=)
EP (1) EP3867253A4 (https=)
JP (1) JP2022502476A (https=)
KR (1) KR20210110566A (https=)
CN (1) CN113272305A (https=)
AU (1) AU2019360204A1 (https=)
BR (1) BR112021007017A2 (https=)
CA (1) CA3115711A1 (https=)
EA (1) EA202190726A1 (https=)
IL (1) IL282252A (https=)
MX (1) MX2021004245A (https=)
SG (1) SG11202103796TA (https=)
WO (1) WO2020081636A1 (https=)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018195397A2 (en) 2017-04-21 2018-10-25 Kyn Therapeutics Indole ahr inhibitors and uses thereof
PT4065582T (pt) 2019-11-26 2025-05-22 Ikena Oncology Inc Derivados polimórficos do carbazol e utilizações dos mesmos
KR20220125323A (ko) 2020-01-10 2022-09-14 이케나 온콜로지, 인코포레이티드 Ahr 억제제 및 이의 용도
WO2021236717A1 (en) 2020-05-20 2021-11-25 Senda Biosciences, Inc. Fused imidazole derivatives as ahr antagonists
US20230227453A1 (en) * 2020-06-10 2023-07-20 Delix Therapeutics, Inc. Tricyclic psychoplastogens and uses thereof
WO2022078356A1 (zh) * 2020-10-15 2022-04-21 山东轩竹医药科技有限公司 杂芳环类AhR抑制剂
IL302346A (en) * 2020-10-28 2023-06-01 Ikena Oncology Inc Combination of an ahr inhibitor with a pdx inhibitor or doxorubicine
KR20230124583A (ko) 2020-11-23 2023-08-25 이난타 파마슈티칼스, 인코포레이티드 신규한 스피로피롤리딘 유래 항바이러스제
US12540141B2 (en) 2020-11-23 2026-02-03 Enanta Pharmaceuticals, Inc. Spiropyrrolidine derived antiviral agents
CN114456178B (zh) * 2021-01-13 2023-06-02 北京华森英诺生物科技有限公司 四氢嘧啶[1,2-b]吲唑-4-胺类衍生物作为AhR抑制剂的用途及制备方法
CN114805361B (zh) * 2021-01-17 2024-02-20 上海凌达生物医药有限公司 一类氨基取代的芳香杂环并吡唑类化合物、制备方法和用途
WO2022235605A1 (en) 2021-05-04 2022-11-10 Enanta Pharmaceuticals, Inc. Novel macrocyclic antiviral agents
WO2023086352A1 (en) 2021-11-12 2023-05-19 Enanta Pharmaceuticals, Inc. Novel spiropyrrolidine derived antiviral agents
WO2023086350A1 (en) 2021-11-12 2023-05-19 Enanta Pharmaceuticals, Inc. Alkyne-containing antiviral agents
US11919910B2 (en) 2021-11-12 2024-03-05 Enanta Pharmaceuticals, Inc. Spiropyrrolidine derived antiviral agents
US11993600B2 (en) 2021-12-08 2024-05-28 Enanta Pharmaceuticals, Inc. Saturated spirocyclics as antiviral agents
WO2023137007A1 (en) * 2022-01-11 2023-07-20 Enanta Pharmaceuticals, Inc. Processes for the preparation of 4,6,7-trifluoro-1h-indole-2-carboxylic acid
WO2023196307A1 (en) 2022-04-05 2023-10-12 Enanta Pharmaceuticals, Inc. Novel spiropyrrolidine derived antiviral agents
AU2023249795A1 (en) 2022-04-08 2024-10-17 Shy Therapeutics, Llc Compounds that interact with ras superfamily proteins for treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
CN117624168A (zh) * 2022-08-19 2024-03-01 德明药泰生物技术(深圳)有限公司 稠环杂环类化合物及其制备方法和应用
AU2023377192A1 (en) 2022-11-07 2025-05-22 Kyoto University Nitrogen-containing heterocyclic compound
KR20240169284A (ko) 2023-05-24 2024-12-03 경희대학교 산학협력단 AhR-매개 질환의 예방, 개선 또는 치료용 약학적 조성물
WO2025114771A1 (en) 2023-11-29 2025-06-05 Latvian Institute Of Organic Synthesis A new class of aryl hydrocarbon receptor antagonists and their optimisation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721356A (en) * 1989-09-15 1998-02-24 Gensia, Inc. Orally active adenosine kinase inhibitors
EP1610774A4 (en) * 2003-04-09 2008-07-16 Exelixis Inc TIE-2 MODULATORS AND METHODS OF USE
PE20051128A1 (es) * 2004-02-25 2006-01-16 Schering Corp Pirazolotriazinas como inhibidores de quinasa
PE20100362A1 (es) * 2008-10-30 2010-05-27 Irm Llc Derivados de purina que expanden las celulas madre hematopoyeticas
JP2018525345A (ja) * 2015-07-01 2018-09-06 ノースウェスタン ユニバーシティ 置換キナゾリン化合物及びグルコセレブロシダーゼ活性の調節のためのその使用
TW201811799A (zh) * 2016-09-09 2018-04-01 美商英塞特公司 吡唑并嘧啶化合物及其用途
WO2018195397A2 (en) * 2017-04-21 2018-10-25 Kyn Therapeutics Indole ahr inhibitors and uses thereof

Similar Documents

Publication Publication Date Title
JP2022502476A5 (https=)
BR112019017762A2 (https=)
BR112021018450A2 (https=)
BR112021017892A2 (https=)
BR112021016821A2 (https=)
BR112021017939A2 (https=)
BR112021016996A2 (https=)
BR112021008711A2 (https=)
BR112019016141A2 (https=)
AU2020104490A5 (https=)
BR112021013944A2 (https=)
BR112021018452A2 (https=)
BR112021018102A2 (https=)
BR112019016142A2 (https=)
BR112019016138A2 (https=)
BR112021018168A2 (https=)
BR112021018093A2 (https=)
BR112021015080A2 (https=)
BR112021012348A2 (https=)
BR112021018250A2 (https=)
BR112021018584A2 (https=)
BR112021013128A2 (https=)
BR112021018484A2 (https=)
BR112021017949A2 (https=)
BR112021018084A2 (https=)